title: Renal transplantation in amyloidosis and MIDD.
abstract: Amyloidosis and monoclonal immunoglobulin deposition disease, though rare entities, can wreak havoc on the architecture and functioning of the kidneys. These diseases have a predilection to cause severe renal dysfunction leading to end stage renal disease (ESRD). In recent years, the available treatments for these diseases have expanded and afflicted patients are living longer, but with advanced kidney disease. Because of the complex nature of the pathophysiology and treatment of these diseases, it can be very challenging for a clinician to determine whether or not it is appropriate to refer an affected individual for kidney transplantation.
authors.affiliation: Renal Section, Boston University School of Medicine, 650 Albany Str, 5th floor, Boston, MA, 02118.
authors.forename: Lauren
authors.initials: L
authors.lastname: Stern
authors.affiliation: Renal Section, Boston University School of Medicine, 650 Albany Str, 5th floor, Boston, MA, 02118.
authors.forename: Andrea
authors.initials: A
authors.lastname: Havasi
mesh_terms: D000686:Amyloidosis / Q000150:complications*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000601:surgery; D016030:Kidney Transplantation; D010265:Paraproteinemias / Q000150:complications